Markers of activated coagulation in acute coronary syndromes.

dentification of potentially useful bloodborne markers in cute coronary syndromes (ACS) is steadily increasing. The linical applications range from prediction and prognosis to efinition and diagnosis. In the center of the markers stand he myocardial proteins and enzymes, because their presence n the circulation reflects myocardial damage and myocyte eath (1). Their concentrations mirror the myocardial lesion ize and, accordingly, provide information on the following rognosis. At the other end of the concentration scale are mproved and sensitive methods that may provide new insight nto the clinical relevance of even very low concentrations. or the individual patient, the concentrations therefore uide therapy directly (diagnosis) and indirectly (risk).